166 related articles for article (PubMed ID: 12544370)
1. Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy.
Hamner MB; Deitsch SE; Brodrick PS; Ulmer HG; Lorberbaum JP
J Clin Psychopharmacol; 2003 Feb; 23(1):15-20. PubMed ID: 12544370
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features.
Kozaric-Kovacic D; Pivac N
Int J Neuropsychopharmacol; 2007 Apr; 10(2):253-61. PubMed ID: 16945162
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial.
Villarreal G; Hamner MB; Cañive JM; Robert S; Calais LA; Durklaski V; Zhai Y; Qualls C
Am J Psychiatry; 2016 Dec; 173(12):1205-1212. PubMed ID: 27418378
[TBL] [Abstract][Full Text] [Related]
4. An open-label assessment of aripiprazole in the treatment of PTSD.
Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG
Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine therapy for posttraumatic stress disorder.
Sattar SP; Ucci B; Grant K; Bhatia SC; Petty F
Ann Pharmacother; 2002 Dec; 36(12):1875-8. PubMed ID: 12452747
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder.
Sokolski KN; Denson TF; Lee RT; Reist C
Mil Med; 2003 Jun; 168(6):486-9. PubMed ID: 12834142
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.
McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE
J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145
[TBL] [Abstract][Full Text] [Related]
10. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.
Villarreal G; Calais LA; Cañive JM; Lundy SL; Pickard J; Toney G
Psychopharmacol Bull; 2007; 40(2):6-18. PubMed ID: 17514183
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population.
Pan PY; Lee MS; Yeh CB
BMC Psychiatry; 2015 Jan; 15():1. PubMed ID: 25609320
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study.
Ahearn EP; Mussey M; Johnson C; Krohn A; Krahn D
Int Clin Psychopharmacol; 2006 Jan; 21(1):29-33. PubMed ID: 16317314
[TBL] [Abstract][Full Text] [Related]
14. Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.
Zhong KX; Sweitzer DE; Hamer RM; Lieberman JA
J Clin Psychiatry; 2006 Jul; 67(7):1093-103. PubMed ID: 16889453
[TBL] [Abstract][Full Text] [Related]
15. Long-Term use of quetiapine in elderly patients with psychotic disorders.
Tariot PN; Salzman C; Yeung PP; Pultz J; Rak IW
Clin Ther; 2000 Sep; 22(9):1068-84. PubMed ID: 11048905
[TBL] [Abstract][Full Text] [Related]
16. A review of atypical antipsychotic medications for posttraumatic stress disorder.
Ahearn EP; Juergens T; Cordes T; Becker T; Krahn D
Int Clin Psychopharmacol; 2011 Jul; 26(4):193-200. PubMed ID: 21597381
[TBL] [Abstract][Full Text] [Related]
17. A preliminary case series on the use of quetiapine for posttraumatic stress disorder in juveniles within a youth detention center.
Stathis S; Martin G; McKenna JG
J Clin Psychopharmacol; 2005 Dec; 25(6):539-44. PubMed ID: 16282834
[TBL] [Abstract][Full Text] [Related]
18. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL
Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.
Pivac N; Kozaric-Kovacic D; Muck-Seler D
Psychopharmacology (Berl); 2004 Oct; 175(4):451-6. PubMed ID: 15064916
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
